Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research note issued to investors on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Evogene Stock Up 0.2 % EVGN opened at $1.42 on Friday. The company has a market capitalization of $7.62 million, a price-to-earnings ratio […]
25 Feb 06:44 · The Markets Daily